Cargando…
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
BACKGROUND: Histone acetylation and deacetylation seem processes involved in the pathogenesis of Ewing sarcoma (EwS). Here histone deacetylases (HDAC) class I were investigated. METHODS: Their role was determined using different inhibitors including TSA, Romidepsin, Entinostat and PCI-34051 as well...
Autores principales: | Schmidt, Oxana, Nehls, Nadja, Prexler, Carolin, von Heyking, Kristina, Groll, Tanja, Pardon, Katharina, Garcia, Heathcliff D., Hensel, Tim, Gürgen, Dennis, Henssen, Anton G., Eggert, Angelika, Steiger, Katja, Burdach, Stefan, Richter, Günther H. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518288/ https://www.ncbi.nlm.nih.gov/pubmed/34654445 http://dx.doi.org/10.1186/s13046-021-02125-z |
Ejemplares similares
-
Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
por: Schmidt, Oxana, et al.
Publicado: (2022) -
Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma
por: H.S. Richter, Günther, et al.
Publicado: (2020) -
Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing’s Sarcoma, Enhancing T Cell Cytotoxicity
por: Biele, Emilie, et al.
Publicado: (2021) -
The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma
por: von Heyking, Kristina, et al.
Publicado: (2016) -
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
por: Ghazy, Ehab, et al.
Publicado: (2022)